Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Spine Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global spine biologics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.

Spine Biologics Market Trends:

Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, surgery type and end user.

Breakup by Product:

  • Spinal Allografts
    • Machined Bones Allograft
    • Demineralized Bone Matrix
  • Bone Graft Substitutes
    • Bone Morphogenetic Proteins
    • Synthetic Bone Grafts
  • Cell Based Matrix
     

Breakup by Surgery Type:

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery
     

Breakup by End User:

  • Hospitals
  • Ambulatory Care Centers
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Surgery Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global spine biologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global spine biologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the surgery type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global spine biologics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Spine Biologics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Spinal Allografts
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Machined Bones Allograft
           6.1.2.2 Demineralized Bone Matrix
        6.1.3 Market Forecast
    6.2    Bone Graft Substitutes
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Bone Morphogenetic Proteins
           6.2.2.2 Synthetic Bone Grafts
        6.2.3 Market Forecast
    6.3    Cell Based Matrix
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Surgery Type
    7.1    Open Spine Surgery
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Minimally Invasive Spine Surgery
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ambulatory Care Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Spinal Surgery Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Orthopedic Clinics
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Arthrex Inc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 SWOT Analysis
        14.3.2    Alphatec Holdings Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Exactech Inc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Johnson & Johnson
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Medtronic plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    NuVasive Inc
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Orthofix Medical Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Stryker Corporation
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Wright Medical Group N.V. 
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 SWOT Analysis
        14.3.10    Zimmer Biomet
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2020
Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2020
Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2020
Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2020
Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2020
Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Global: Spine Biologics Industry: SWOT Analysis
Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2021-2026
Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Spine Biologics Market: Competitive Structure
Table 7: Global: Spine Biologics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links